These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12702999)

  • 41. Diagnosis of coexistent hepatic tumors of different kinds: a challenge from CT and MR imaging.
    Itai Y; Ohtomo K; Kokubo T; Yoshida H; Minami M; Kawauchi N; Okada Y
    Radiat Med; 1989; 7(3):143-9. PubMed ID: 2555846
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of 18F-FDG PET/CT Imaging in Intrahepatic Cholangiocarcinoma.
    Jiang L; Tan H; Panje CM; Yu H; Xiu Y; Shi H
    Clin Nucl Med; 2016 Jan; 41(1):1-7. PubMed ID: 26402131
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intratumoral artery on contrast-enhanced computed tomography imaging: differentiating intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma.
    Tsunematsu S; Chuma M; Kamiyama T; Miyamoto N; Yabusaki S; Hatanaka K; Mitsuhashi T; Kamachi H; Yokoo H; Kakisaka T; Tsuruga Y; Orimo T; Wakayama K; Ito J; Sato F; Terashita K; Nakai M; Tsukuda Y; Sho T; Suda G; Morikawa K; Natsuizaka M; Nakanishi M; Ogawa K; Taketomi A; Matsuno Y; Sakamoto N
    Abdom Imaging; 2015 Aug; 40(6):1492-9. PubMed ID: 25579172
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The value of CA19-9 in diagnosing hepatocellular carcinoma and intrahepatic cholangiocarcinoma].
    Chen Y; Wang ZM; Ren ZG; Le F; Zhang BH; Xia JL; Ye SL; Tang ZY
    Zhonghua Gan Zang Bing Za Zhi; 2006 Apr; 14(4):299-300. PubMed ID: 16635306
    [No Abstract]   [Full Text] [Related]  

  • 45. Small hepatocellular carcinomas in cirrhosis: differences in contrast enhancement effects between helical CT and MR imaging during multiphasic dynamic imaging.
    Hayashida M; Ito K; Fujita T; Shimizu A; Sasaki K; Tanabe M; Matsunaga N
    Magn Reson Imaging; 2008 Jan; 26(1):65-71. PubMed ID: 17566685
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Combined hepatocellular-cholangiocarcinoma].
    Jeen YM; Jin SY
    Korean J Hepatol; 2007 Dec; 13(4):571-5. PubMed ID: 18159156
    [No Abstract]   [Full Text] [Related]  

  • 47. Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET.
    Teefey SA; Hildeboldt CC; Dehdashti F; Siegel BA; Peters MG; Heiken JP; Brown JJ; McFarland EG; Middleton WD; Balfe DM; Ritter JH
    Radiology; 2003 Feb; 226(2):533-42. PubMed ID: 12563151
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MRI of clonorchiasis and cholangiocarcinoma.
    Choi BI; Kim TK; Han JK
    J Magn Reson Imaging; 1998; 8(2):359-66. PubMed ID: 9562062
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Computed tomography features of an intraductal polypoid mass: differentiation between hepatocellular carcinoma with bile duct tumor invasion and intraductal papillary cholangiocarcinoma.
    Jung AY; Lee JM; Choi SH; Kim SH; Lee JY; Kim SW; Han JK; Choi BI
    J Comput Assist Tomogr; 2006; 30(1):18-24. PubMed ID: 16365567
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synchronous occurrence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in both lobes of the liver.
    Topaloğlu S; Sağlam K; Çalık A; Cobanoğlu Ü; Öztürk MH
    Turk J Gastroenterol; 2014 Apr; 25(2):209-11. PubMed ID: 25003684
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A case report of synchronous double primary liver cancers combined with early gastric cancer.
    Chang JY; Kim BH; Hong SW; Kim YW; Oh JH
    Korean J Intern Med; 2003 Jun; 18(2):115-8. PubMed ID: 12872450
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [In vivo proton magnetic resonance spectroscopy of hepatocellular carcinoma and cholangiocarcinoma].
    Dong AS; Tian JM; Lu JP; Zuo CJ; Wang L; Wang J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Apr; 31(2):151-4. PubMed ID: 19507591
    [TBL] [Abstract][Full Text] [Related]  

  • 53. LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.
    Schellhaas B; Wildner D; Pfeifer L; Goertz RS; Hagel A; Neurath MF; Strobel D
    Ultraschall Med; 2016 Dec; 37(6):627-634. PubMed ID: 27486793
    [No Abstract]   [Full Text] [Related]  

  • 54. MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma.
    Sammon J; Fischer S; Menezes R; Hosseini-Nik H; Lewis S; Taouli B; Jhaveri K
    Cancer Imaging; 2018 Feb; 18(1):8. PubMed ID: 29486800
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma.
    Rimola J; Forner A; Reig M; Vilana R; de Lope CR; Ayuso C; Bruix J
    Hepatology; 2009 Sep; 50(3):791-8. PubMed ID: 19610049
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Evaluation of immunohistochemical markers for differential diagnosis of hepatocellular carcinoma from intrahepatic cholangiocarcinoma].
    Dong H; Cong WL; Zhu ZZ; Wang B; Xian ZH; Yu H
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):702-5. PubMed ID: 19173916
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combined hepatocellular-cholangiocarcinoma. Cytologic findings in four cases.
    Dusenbery D
    Acta Cytol; 1997; 41(3):903-9. PubMed ID: 9167724
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A mixed hepatocellular carcinoma and cholangiocarcinoma: dual expression of biliary-type cytokeratin and hepatocyte specific marker.
    Tanaka S; Hirohashi K; Uenishi T; Yamamoto T; Hamba H; Kubo S; Tanaka H; Shuto T; Ogawa M; Kinoshita H
    Hepatogastroenterology; 2004; 51(57):839-41. PubMed ID: 15143930
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The ins and outs of liver imaging.
    O'Neill EK; Cogley JR; Miller FH
    Clin Liver Dis; 2015 Feb; 19(1):99-121. PubMed ID: 25454299
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnostic imaging of hepatic lesions in adults.
    Lamba R; Fananapazir G; Corwin MT; Khatri VP
    Surg Oncol Clin N Am; 2014 Oct; 23(4):789-820. PubMed ID: 25246050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.